MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with C

Cyproterone

Cyproterone 2mg capsules

No stability information

Stability notes for Cyproterone 2mg capsules

There are no stability notes for this medicine.

Supplier

Cyproterone 2mg capsules (Special Order)

Cyproterone 10mg tablets

No stability information

Stability notes for Cyproterone 10mg tablets

There are no stability notes for this medicine.

Supplier

Cyproterone 10mg tablets (Special Order)

Cyproterone 50mg tablets

Use with caution

Stability notes for Cyproterone 50mg tablets

Manufacturer recommends storing in original container.
No stability data in MCAs available.

Provenance

This recommendation is based on the products Androcur 50mg tablets (Advanz Pharma).

Suppliers (8) of Cyproterone 50mg tablets
Androcur 50mg tablets (Advanz Pharma)
Cyprostat 50mg tablets (Advanz Pharma)
Cyproterone 50mg tablets (A A H Pharmaceuticals Ltd)
Cyproterone 50mg tablets (Alliance Healthcare (Distribution) Ltd)
Cyproterone 50mg tablets (Almus Pharmaceuticals Ltd)
Cyproterone 50mg tablets (Medihealth (Northern) Ltd)
Cyproterone 50mg tablets (Phoenix Healthcare Distribution Ltd)
Cyproterone 50mg tablets (Sigma Pharmaceuticals Plc)

Cyproterone 100mg tablets

Use with caution

Stability notes for Cyproterone 100mg tablets

Manufacturer recommends storing in original container.
No stability data in MCAs available.

Provenance

This recommendation is based on the products Androcur 50mg tablets (Advanz Pharma) and Cyproterone 100mg tablets (Kent Pharma UK Ltd).

Suppliers (5) of Cyproterone 100mg tablets
Cyproterone 100mg tablets (A A H Pharmaceuticals Ltd)
Cyproterone 100mg tablets (Alliance Healthcare (Distribution) Ltd)
Cyproterone 100mg tablets (Medihealth (Northern) Ltd)
Cyproterone 100mg tablets (Phoenix Healthcare Distribution Ltd)
Cyproterone 100mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.